Leslie Holsinger

Insider Reports History

Entity
Individual
Location
C/O Cortexyme, Inc., 269 East Grand Ave., South San Francisco, CA
Signature
/s/ Caryn Gordon McDowell, as Attorney-in-Fact for Leslie Holsinger
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Leslie Holsinger:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cortexyme, Inc. EVP, Preclinical Development Common Stock 148K $139K $0.94 Jun 6, 2022 Direct
Cortexyme, Inc. EVP, Preclinical Development Stock option (right to buy) 125K Jan 3, 2022 Direct

Insider Reports Filed by Leslie Holsinger

Symbol Company Period Transactions Value $ Form Type Date Filed Role
QNCX Cortexyme, Inc. Jun 6, 2022 1 -$31.2K 4 Jun 8, 2022 EVP, Preclinical Development
QNCX Cortexyme, Inc. Mar 3, 2022 1 $0 4 Mar 4, 2022 EVP, Preclinical Development
QNCX Cortexyme, Inc. Jan 3, 2022 1 $0 4 Jan 5, 2022 EVP, R&D